National MS Society Details Pathways to Cures Roadmap & Expert Voices: Vitamin D and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the National Multiple Sclerosis Society detailed its Pathways to Cures Roadmap and ways to advance each pathway, w...
8 Apr 202215min
Key to Unlocking Blood-brain Barrier Discovered & Jokes and Humor in MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how researchers have discovered the key to bypassing the blood-brain barrier, which may lead to the developm...
6 Apr 202211min
Scientists Review State of Cannabis Research in MS & MS Wound Management
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how cannabis-based medications could ease muscle spasms, decrease pain, and aid in sleep for people with ...
4 Apr 202210min
STAT5 Protein Complex Implicated in MS Autoimmunity & One Month of MS Awareness Isn’t Enough
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how a four-protein complex of the protein STAT5 could be involved in the development of MS-like autoimmune disease in m...
1 Apr 20228min
Jenn Powell Talks to Tim Coetzee, from the National Multiple Sclerosis Society
Tim Coetzee is the Chief Advocacy, Services and Science Officer at the National Multiple Sclerosis Society. Tim leads all efforts focused on state and federal advocacy, marketing and communications, s...
31 Mar 202239min
No Increased Risk Found From Ocrevus Exposure in Pregnancy & Stem Cell Transplant Gaining Ground
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found no increased risks for women with MS or their babies after exposure to Ocrevus before or during preg...
30 Mar 202220min
NervGen to Enroll 2nd Volunteer Group in NVG-291 Trial & The Invisible Symptoms of MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical tri...
28 Mar 20229min
Myelin-restoring Medication Found Safe & Finding Purpose With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how PIPE-307, a myelin-restoring treatment, was found safe in a Phase 1 clinical trial in 70 healthy ...
25 Mar 20228min
